Symptoms requiring routine medical review: Bloating that persists beyond 46 weeks despite dietary modifications and adequate dose titration Symptoms that significantly impact quality of life or ability to maintain adequate nutrition New or worsening heartburn or regurgitation, which may indicate gastro-oesophageal reflux disease (GORD) Changes in bowel habit such as persistent diarrhoea or constipation Concerns about medication adherence due to gastrointestinal side effects Your healthcare professional may recommend investigations to exclude other causes of bloating, particularly if symptoms are atypical or severe
If a patient opts to begin medication, it is essential to monitor and promptly address any emerging signs of exacerbation of eating disorder psychopathology (e.g., adoption of extreme and rigid dietary rules, skipping meals, self-inducing vomiting)
Appetite Changes Semaglutide strongly reduces appetite
Reducing fat intake, eating smaller, frequent meals, and staying hydrated help minimize nausea and maintain stable stool patterns during the initial treatment phase
Those taking tirzepatide lost up to 15.7% (34.4lbs or 15.6kgs) of body weight for the efficacy estimandii
